NCT02028871View on ClinicalTrials.gov

Intranasal Insulin for Weight Management During Smoking Cessation

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Tobacco Abstinence Syndrome
Interventions
DRUG

Intranasal Insulin

DRUG

Placebo

Trial Locations (2)

87131

UNM College of Pharmacy, Albuquerque

Unknown

UNM College of Pharmacy, Albuquerque

All Listed Sponsors
lead

Ajna Hamidovic

OTHER

NCT02028871 - Intranasal Insulin for Weight Management During Smoking Cessation | Biotech Hunter | Biotech Hunter